FDAnews
www.fdanews.com/articles/75011-tengion-inc-completes-39-million-series-a-round

TENGION, INC. COMPLETES $39 MILLION SERIES 'A' ROUND

August 4, 2005

Tengion, Inc., a leader in the field of regenerative medicine, announced that the company recently completed a $39 million Series A financing. The company is actively working with Food and Drug Administration to advance the development of its lead products, which are organs and tissues derived from a patient's own cells that can be used to replace the patient's diseased or impaired organ or tissue.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-03-2005/0004081467&EDATE=)